MedTrace Logo

Dose Response Study of a Fermented Yogurt on the Immune System and Gut Health

NCT00730626 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 58

Last updated 2009-06-22

No results posted yet for this study

Summary

The purpose of this study is to determine the dose-response effect of a yogurt containing a combination of bifidobacterium Lactis (BB-12) and Lactobacillus Acidophilus (LA-5) and green tea extract on markers of the immune system and gut health in healthy subjects. We hypothesize that the response of the immune function will be dose-dependent of the probiotics found in the fermented yogurt.

Conditions

  • Immune System

Interventions

DIETARY_SUPPLEMENT

Yogurt with 1X10E9 BB-12 and LA-5

100g of yogurt containing the probiotics L.acidophilus and B.lactis (concentrations of 1x10E9 of each probiotics) with 40 mg of green tea extract, once a day for 10 weeks.

DIETARY_SUPPLEMENT

Yogurt with 1X10E10 BB-12 and LA-5

100g of yogurt containing the probiotics L.acidophilus and B.lactis (concentrations of 1x10E10 of each probiotics) with 40 mg of green tea extract, once a day for 10 weeks.

DIETARY_SUPPLEMENT

Yogurt Placebo

100g of yogurt placebo containing no probiotics and no green tea extract, once a day for 10 weeks.

Sponsors & Collaborators

  • Aliments ULTIMA Foods Inc.

    collaborator INDUSTRY

  • McGill University

    collaborator OTHER

  • TransBiothec

    collaborator UNKNOWN

  • Laval University

    lead OTHER

Principal Investigators

  • Benoît Lamarche, PhD · Institute of Nutraceuticals and Functional Foods (INAF), Laval University.

  • Jacques Hébert, MD · Faculty of Medicine, Laval University.

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-08-31
Primary Completion
2008-12-31
Completion
2009-05-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00730626 on ClinicalTrials.gov